Innovation Capital

Type

Other

Status

Active

Total investments

75

Average round size

8M

Portfolio companies

43

Rounds per year

2.78

Lead investments

8

Follow on index

0.29

Exits

21

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyMobileHealth CareManufacturingMedical DevicePharmaceuticalElectronicsTelecommunications

Summary

In 1996 was created Innovation Capital, which is appeared as VC. The company was established in Australia. The main office of represented VC is situated in the Sydney.

The current fund was established by Ian Bund, Michael A. Quinn. The overall number of key employees were 4.

The important activity for fund was in 2000. The fund is constantly included in 2-6 investment rounds annually. This Innovation Capital works on 7 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Innovation Capital, startups are often financed by Idinvest Partners, Sofinnova Investments, CDC Enterprises. The meaningful sponsors for the fund in investment in the same round are Ventech, Sofinnova Investments, Omnes Capital. In the next rounds fund is usually obtained by Ventech, Bpifrance, 123Venture.

The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is no match between the location of its establishment and the land of its numerous investments - France. Besides, a startup requires to be at the age of 16-20 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Web Hosting, Business Intelligence. Among the various public portfolio startups of the fund, we may underline Ekinops, VPIsystems, Kuros Biosciences

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
75
Lead investments
8
Exits
21
Rounds per year
2.78
Follow on index
0.29
Investments by industry
  • Health Care (25)
  • Manufacturing (21)
  • Biotechnology (20)
  • Software (19)
  • Pharmaceutical (13)
  • Show 68 more
Investments by region
  • France (41)
  • United States (15)
  • Germany (2)
  • Denmark (2)
  • United Kingdom (3)
  • Show 1 more
Peak activity year
2009

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
23M
Group Appearance index
0.88
Avg. company exit year
24
Avg. multiplicator
3.11

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
6WIND 01 Jan 2000 Software, Information Technology, Robotics, Telecommunications, Virtualization Seed Ile-de-France, France, France
Fabrico SaaS 24 Oct 2023 Software, Manufacturing, Business Information Systems Seed 802K England, London, United Kingdom
Tempo 02 Feb 2017 Internet, Human Resources, Recruiting, Marketplace Seed England, London, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.